Litigation Details for In Re: Purdue Pharma L.P. (S.D.N.Y. 2021)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2021-09-09
Court	District Court, S.D. New York	Date Terminated
Cause	28:0158 Notice of Appeal re Bankruptcy Matter (BA	Assigned To	Colleen McMahon
Jury Demand	None	Referred To
Patents	6,005,001; 6,031,007; 7,658,945; 8,008,006; 9,000,002; 9,000,011; 9,005,016; 9,730,934
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2021-11-14	158		6.5 $ 6.5 $ 6.5 $ 1.5 23.2% $ 0.3 4.6%… 6.5 $ 6.5 $ 6.5 $ 1.5 23.2% $ 0.3 4.6%… tax basis in certain of its assets, including patents and other intangible property. If NewCo does not…tax basis in certain of those assets, including patents and other intangible property, which deductions…real property and equipment and certain brands, patents and other intangible assets, which liquidation	External link to document
2022-02-13	350	Exhibit District Court Civil Docket	and proceed as follows: Appellants to have from 9:00-11: 15 to present argument. We will…argument will begin at 9:00 AM. Appellants have from 9:00-11:15 to present argument. Pro se…OxyContin patent capped its earnings until 2008, when it was definitively held that the patent was valid… the Sacklers with those against the Debtors is patent. (See, e.g., Dkt. No. 103-7, at A-1553; Dkt. No	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document